We reported that inhibition of CD154 expression by HCQ in T cells from SLE patients may be due to directly attenuating the CD154 transcription by inhibiting NFATc2 translocation and NFATc1 expression, not simply due to blocking T-cell activation (Fig. 5). Here, NFATC2 is linked to systemic lupus erythematosus.